Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

Restoring hair bulb immune privilege is crucial for managing alopecia areata.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

The document concludes that alopecia areata is an autoimmune disease without a definitive cure, but treatments like corticosteroids are commonly used.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

The cause of Frontal Fibrosing Alopecia is unclear, diagnosis involves clinical evaluation and various treatments exist, but their effectiveness is uncertain.

Low vitamin D might be linked to certain types of hair loss, and supplements could help, but more research is needed.

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.

New treatments for hair loss are showing promise due to better understanding of genetics and the immune system.

308-nm excimer light therapy helped over a third of treatment-resistant alopecia universalis patients regrow most of their hair.

Targeting immune tolerance issues in Alopecia Areata could restore hair growth and maintain remission.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

A man had temporary hair loss from radiation during a medical procedure but regrew his hair after treatment with minoxidil lotion.

Alopecia Areata is an autoimmune disease causing hair loss, with no cure yet, but research may lead to new treatments.

The document concludes that alopecia areata is an unpredictable autoimmune hair loss condition with no cure, but various treatments exist that require personalized approaches.

Higher IL-21 levels may help predict alopecia areata activity.

M-CSF-stimulated myeloid cells can cause alopecia areata in mice.

Alopecia areata may be treated by using EGCG to balance immune cells and reduce inflammation.

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

Some treatments can help with a hair loss condition called alopecia areata, but none ensure lasting results; choices depend on the person, with JAK inhibitors showing promise for severe cases.

Mostly postmenopausal Caucasian women get Frontal Fibrosing Alopecia, which often includes eyebrow loss and has limited treatment success.

Keratin 17 is crucial for early hair strength and cell survival.

No single treatment is consistently effective for alopecia areata, and more research is needed.

Alopecia is a key indicator of thallium poisoning.

Children, especially teenagers, can get severe SARS-CoV infection with symptoms similar to adults, but they typically recover well with supportive care.

Alopecia areata is a type of hair loss that can lead to complete baldness, often associated with other autoimmune conditions, and half of the cases may see hair return within a year.

Chemotherapy often causes temporary hair loss, which is distressing and needs better treatment and support.

Dutasteride may help stabilize Frontal Fibrosing Alopecia, but more research is needed.